AI Assistant
Blog
Pricing
Log In
Sign Up
P433. Canadian patient and caregiver perspectives on subsequent entry biologics / biosimilars for inflammatory bowel disease
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
